Mckinsey and Company
DECEMBER 21, 2021
The COVID-19 pandemic has prompted pharma companies to rethink their organizational strategies. A survey of executives suggests where value might lie.
Internal Audit 360
DECEMBER 21, 2021
I f 2020 was the “Year of Covid,” 2021 will go down as a year of trying to return to normal. In many ways we did get back some semblance of normalcy, as kids returned to school, fans returned to sports venues, and shops and restaurants reopened. Yet, in many other ways things remained far from normal this year. Face coverings are still a common sight, many offices remain closed or mostly empty as remote work has become routine, and the Omicron variant continues to push case numbers up.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mckinsey and Company
DECEMBER 21, 2021
Before the COVID-19 pandemic, millions visited the Big Apple every year to fulfill their travel and business aspirations. What will it take for them to return?
Meade & Moore
DECEMBER 21, 2021
Recent technological and digital advances are fueling the rise of smart, automated manufacturing facilities. Known as Industry 4.0, these advances represent the future of manufacturing and industry. Also referred to as the fourth industrial revolution, Industry 4.0 is causing massive disruption to the manufacturing industry and its workforce. Digital transformation of the industrial and production environment lies at the heart of Industry 4.0, which represents a new stage in the organization of
Speaker: Susan Spencer, Principal of Spencer Communications
Intent signal data can go a long way toward shortening sales cycles and closing more deals. The challenge is deciding which is the best type of intent data to help your company meet its sales and marketing goals. In this webinar, Susan Spencer, fractional CMO and principal of Spencer Communications, will unpack the differences between contact-level and company-level intent signals.
Mckinsey and Company
DECEMBER 21, 2021
Seasoned comic artist Tom Gauld discusses his first foray into children’s books, the importance of bedtime rituals, and how his daughters inspired the making of a fairy tale.
Fox Corporate Finance
DECEMBER 21, 2021
On Thursday, December 9, 2021, Die Welt reports on the current challenges for automotive suppliers due to the semiconductor shortage. Arno Fuchs outlines his view as financing expert and indicates which companies are at particular. Read more. The post 100 years, 1000 employees – but the perfect storm was too strong | Die Welt December 9, 2021 – Quotes by FCF appeared first on FCF Fox Corporate Finance GmbH.
Business Valuation Zone brings together the best content for business valuation professionals from the widest variety of industry thought leaders.
Fox Corporate Finance
DECEMBER 21, 2021
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 11/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life. Read more. The post FCF Life Sciences Venture Capital Monitor – Europe 11/2021 published appeared first on FCF Fox Corporate Finance GmbH.
IT Valuations
DECEMBER 21, 2021
Now is the time to finally get a handle on understanding your company’s financials and accounting. Listen, I get it. Most of us business owners did not go to school to start a business. Rather, we followed our interests and our passions, and then only later did we end up starting our own companies. But this financial and accounting knowledge gap will come back to haunt you.
Fox Corporate Finance
DECEMBER 21, 2021
November 2021: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend. Read more. The post Venture Capital Sentiment Tracker – November 2021 appeared first on FCF Fox Corporate Finance GmbH.
Expert insights. Personalized for you.
133 
Let's personalize your content